|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.47 USD | +16.86% |
|
+10.22% | +14.11% |
| 07-17 | Xencor's Cancer Drug Study Selected for Oral Presentation at ESMO; Shares Rise | MT |
| 05-13 | Xencor, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 03:00 PM |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 19.85 | 19.85 | 24.29 |
| Spread/Res. | -11.99% | -11.99% | -28.08% |
| Spread/Supp. | +30.76% | +30.76% | +55.70% |
| Support | 13.36 | 13.36 | 11.22 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- XNCR Stock
- Charts Xencor, Inc.
Select your edition
All financial news and data tailored to specific country editions
